Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer.

Khorana, Alok A

Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer. [electronic resource] - The New England journal of medicine 02 2019 - 720-728 p. digital

Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1533-4406

10.1056/NEJMoa1814630 doi


Administration, Oral
Adult
Aged
Aged, 80 and over
Antineoplastic Agents--therapeutic use
Double-Blind Method
Factor Xa Inhibitors--adverse effects
Female
Hemorrhage--chemically induced
Humans
Incidence
Intention to Treat Analysis
Kaplan-Meier Estimate
Male
Middle Aged
Neoplasms--complications
Risk Factors
Rivaroxaban--adverse effects
Treatment Outcome
Venous Thromboembolism--etiology